Transfusion

Titel Veröffentlichungsdatum Sprache Zitate
Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score–matched case‐control analysis2004/12/22English129
Evaluation and management of postpartum hemorrhage: consensus from an international expert panel2014/03/12English129
The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery2009/01/23English129
Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products2006/09/21English129
Guidelines for assessing appropriateness of pediatric transfusion2002/11/01English128
Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction2005/06/10English128
Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity2005/12/14English128
Clinical toxicity and laboratory effects of granulocyte‐colony‐ stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures1996/07/01English128
Blood use in war and disaster: lessons from the past century2003/10/24English128
The type and screen: a safe alternative and supplement in selected surgical procedures1977/03/04English128
Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID‐19) pandemic affecting Washington State2020/04/27English127
Mechanisms of red blood cell transfusion‐related immunomodulation2018/01/30English127
Photochemical treatment of platelet concentrates with amotosalen and long‐wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria2004/09/22English127
The effect of whole‐blood donor adverse events on blood donor return rates2006/07/28English127
The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine2014/08/06English127
The consequences of temporary deferral on future whole blood donation2007/05/29English127
Photochemical treatment of plasma with amotosalen and long‐wavelength ultraviolet light inactivates pathogens while retaining coagulation function2006/06/26English127
Trends in United States blood collection and transfusion: results from the 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey2016/06/15English127
Anti‐D immunization by DEL red blood cells2005/03/22English127
Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products1989/11/12English126
Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs2004/01/01English126
Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood–derived platelets and apheresis platelets2007/02/16English126
Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure2002/01/01English126
Collection and transfusion of blood and blood components in the United States, 19891993/02/01English126
A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology2010/10/29English126
Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long‐wavelength ultraviolet light2005/03/22English125
Predicting blood donation intentions and behavior among Australian blood donors: testing an extended theory of planned behavior model2009/01/23English125
Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction2004/01/01English125
Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission2002/05/01English125
Proposed standardization of methods for determining the 24‐hour survival of stored red cells1984/03/04English124